Sorrel Medical Appoints Bentsi Algazi Vice President of Operations, as Company Gears Up for Clinical and Commercial Manufacturing

Former West Pharmaceutical Site Manager Joins Wearable Drug Delivery Innovator to Advance Manufacturing Capabilities

Sorrel Medical (, a developer and manufacturer of wearable drug delivery devices, today announced the appointment of Bentsi Algazi as Vice President of Operations to meet growing interest in its award-winning wearable self-injection devices.

As VP Operations, Algazi will oversee all of Sorrel’s supply chain, engineering, production and vendor management activities. He brings over 20 years’ managerial experience in R&D, operations, procurement and production management in both high-tech and medical device markets, with a proven history of success in implementing customized innovative management and business solutions.

“Sorrel’s proprietary wearable drug delivery platform is receiving considerable attention from leading pharmaceutical and biotech companies amid growing demand for patient-friendly and partner-focused solutions,” said Andrei Yosef, PhD, CEO for Sorrel Medical. “As Sorrel progresses from R&D to manufacturing, we continue to invest in our Operations team. We are delighted to welcome Bentsi to Sorrel, where his extensive experience in operations and supply chain management will prove integral to expediting our production capabilities.”

Algazi joins Sorrel from Juganu Ltd., a leader in smart lighting, networking and sensing solutions for municipal and commercial markets, where he served as Chief Operations Officer. Prior to Juganu, he was Micro-Infusion R&D Site Manager at West Pharmaceutical Services, Inc., leading the team responsible for bringing the company’s SmartDose® wearable injector to commercialization. Before joining West, Bentsi served as COO at PowerPaper, a developer of micro-electric solutions for cosmetic & RFID applications.

“Sorrel Medical is emerging as a key player in the wearable injector and connected drug delivery space, bringing innovative solutions for the safe and efficient self-administration of new biologic medications,” said Bentsi Algazi. “I am excited to join Sorrel’s dynamic team with a culture of excellence committed to working with pharmaceutical partners to enhance the self-administration experience for potentially millions of patients.”